Last Chance!

  • 00Days
  • 00Hours
  • 00Minutes
  • 00D
  • 00H
  • 00M

Practitioners: Build a Thriving Practice Starts Here

World Suicide Prevention Day: Suicide Remains a Leading Global Cause of Death; Communities Across the World Seek Expanded Use of Psychedelics as Medicine to Treat Depression

Psychable Provides Comprehensive Information and Safe Access to Practitioners Through Supportive Online Community

LOS ANGELES, Sept. 10, 2021 (GLOBE NEWSWIRE) — Every 40 seconds, someone in the world dies of suicide and, for every suicide that results in death, there are as many as 40 unsuccessful attempts. Today is World Suicide Prevention Day and Psychable, the #1 most trusted and comprehensive online community dedicated to connecting those interested in legally exploring psychedelic-assisted therapy with practitioners in the space, is doing its part to advance the conversation surrounding the use of psychedelics as medicine to treat depression.

Psychedelic-assisted therapy is the use of psychedelics for healing purposes, often taking the form of a psychedelic being administered under the supervision of a therapist. In recent years, ketamine and the innovation of its use for treating different forms of depression has become increasingly more interesting as it is evident that it can provide rapid relief to persons with treatment-resistant depression. The treatment is now offered in therapeutic settings via a variety of administration routes, including infusion, intramuscular injection, intranasally, by mouth, and even sublingually.

Recent studies have shown psychedelic-assisted therapy can have long-lasting, fast-acting, and impactful results when it comes to treating those suffering with depression, trauma and addiction. When administered under the supervision of or with the aftercare of a therapist, evidence shows that substances such as ketamine, MDMA, and psilocybin are successful at reducing fear and defensiveness, enhancing introspection and breaking traumatic thought patterns to provide rapid and lasting relief.

Psychable is committed to connecting those interested in legally exploring psychedelic-assisted therapy as a treatment for depression with practitioners in the space. Candidates looking for treatment and practitioners will find support for every stage of the psychedelic journey through the Psychable community at www.Psychable.com.

“Suicide is a unique cause of death in the sense that it is fully preventable. With overdue conversations happening surrounding access to mental health resources, the increase of approved psychedelic-assisted therapy depression treatment options and enhanced understanding surrounding the use of psychedelics as medicine, our mission to connect those who struggle with depression to practitioners in the psychedelic-assisted therapy space is more imperative than ever,” said Jemie Sae Koo, Co-Founder and CEO of Psychable.

Psychable was founded by serial entrepreneur Jemie Sae Koo with the belief that psychedelics can provide meaningful and transformative treatments for not only those struggling with a myriad of ailments, but also those looking to transform their lives for the better. It is with having her own transformative experiences with psychedelic medicine that led her to pursuing a Master of Arts Degree in Psychology with a focus on Psychedelic-Assisted Therapy, she has curated a team of experts with deep experience to lead the Psychable community to support all phases of the journey from information to integration.

Psychable is the holistic solution to connect psychedelic-assisted therapy practitioners with candidates seeking services. The platform streamlines the research period for candidates by offering filters for search including geolocation, treatment type, training or credentials, and other preferences to match with practitioners of their choosing. A true one-stop community for discovering and booking psychedelic-assisted treatments, Psychable’s network allows practitioners and patients to communicate directly with one another to discuss the best possible treatment plans and allows users to share recommendations and reviews of practitioners. Psychable also hosts an extensive library of proprietary, medically reviewed articles on all aspects of psychedelics as part of its mission to continue to inform and educate the world about the power of psychedelics as part of holistic health.

Psychable is open to all those who seek information on psychedelic-assisted therapy and practitioners who can help. For more information, to create your profile or secure your listing, please visit www.Psychable.com. Follow along via social media on LinkedinInstagramTwitter, and Facebook.

About Psychable
Psychable is the #1 most trusted and comprehensive online community connecting those who would like to legally explore the healing power of psychedelics with medically and peer-reviewed practitioners. The community offers support for those seeking information, current patients and practitioners wherever they are in their journey with psychedelic-assisted therapy. Our mission is to transform the lives of millions of people suffering with conditions such as depression, PTSD and addiction by connecting them to psychedelic-based treatments, including integration, psychedelic-assisted therapy and retreats. Psychable was launched in 2021 by Jemie Sae Koo, a successful entrepreneur whose transformative experiences with psychedelic medicine led her to pursue a Master of Arts Degree in Psychology with a focus on Psychedelic-Assisted Therapy. The platform is supported by a passionate team of experts in psychology, business, medicine, and law. For more information on our mission and community, visit https://psychable.com/, or follow us on LinkedinInstagramTwitter, and Facebook.

Psychable, Inc.
[email protected]

Share This Article

Already have account?

Welcome! Sign Up to

Start your journey with us

Or continue with the following options.

By signing up, you agree to and acknowledge Psychable’s Terms of Service and Privacy Policy.